Neervannan Seshadri

Chief Operating OfficerTarsus Pharmaceuticals, Inc. (TARS) · full profile →Form 4 · filed Mar 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$772K
Net Open-Market Flow
-$772K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2026Sell(S)5K$67.00$307K86K
Mar 18, 2026Sell(S)4K$68.71$248K90K
Mar 17, 2026Sell(S)3K$69.42$217K94K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001827584-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly: